Literature DB >> 6243882

Ultrastructural study of stroma in human mammary carcinoma.

L Ghosh, B C Ghosh, T K Das Gupta.   

Abstract

This investigation was designed to study the origin of the stromal component of human mammary carcinoma. Tissues from 30 proved breast carcinomas were studied. Under a light microscope with special stains, an increased connective tissue component was seen in carcinoma. Gluteraldehyde-fixed tissue was examined under an electron microscope. The stroma appeared to be composed of fibroblastic, myofibroblastic, histiocytic and primitive mesenchymal cells. Elastic fibers were intimately intermingled with collagen and reticulin and seen in close association with carcinoma cells. In some areas they were seen inside the carcinoma cells with discontinuous cytoplasmic membrane, as if they were formed by the cancer cells. This observation suggests that breast carcinoma cells play an important role in the production of elastic fibers in association with stromal cells and also stimulate the proliferation of the stromal cellular component.

Entities:  

Mesh:

Year:  1980        PMID: 6243882     DOI: 10.1016/0002-9610(80)90260-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Cytoskeletal characteristics of myofibroblasts in benign neoplastic and reactive fibroblastic lesions.

Authors:  T Hasegawa; T Hirose; E Kudo; J Abe; K Hizawa
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Assessment of Stromal Elastin Fibers in Breast Cancer and Fibroadenomas: Is There a Correlation With Ultrasound Elastography Findings?

Authors:  Nurşen Toprak; İbrahim Aras; Osman Toktaş; Adem Yokuş; Ali Mahir Gündüz
Journal:  Eur J Breast Health       Date:  2022-04-01

3.  Targeted matrisome analysis identifies thrombospondin-2 and tenascin-C in aligned collagen stroma from invasive breast carcinoma.

Authors:  Lucas A Tomko; Ryan C Hill; Alexander Barrett; Joseph M Szulczewski; Matthew W Conklin; Kevin W Eliceiri; Patricia J Keely; Kirk C Hansen; Suzanne M Ponik
Journal:  Sci Rep       Date:  2018-08-28       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.